Evidence map›Paper›PMID 42295762›Full record

ArticleJAMA network open2026

COVID-19 Vaccine Effectiveness Among Older Adults.

Charlotte Laniece Delaunay, Alberto Mateo-Urdiales, Gloria Pérez-Gimeno, Karen O'Reilly, Marina Uras, Annika Erdwiens, Ivan Mlinaric, Gergo Túri, Iván Martínez-Baz, Adam Meijer and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Charlotte Laniece DelaunayEpiconcept, Paris, France.
Alberto Mateo-UrdialesDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Gloria Pérez-GimenoDepartment of Communicable Diseases, National Centre of Epidemiology, Institute of Health Carlos III; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain.
Karen O'ReillyHealth Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Marina UrasSorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique, Paris, France.
Annika ErdwiensDepartment for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.
Ivan MlinaricCroatian Institute of Public Health, Zagreb, Croatia.
Gergo TúriNational Laboratory for Health Security, Epidemiology and Surveillance Centre, Semmelweis University, Budapest, Hungary.
Iván Martínez-BazInstituto de Salud Pública de Navarra, Pamplona, Spain.
Adam MeijerNational Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Ana Paula RodriguesEpidemiology Department, National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
Mihaela LazarCantacuzino National Military Medical Institute for Research and Development, Bucharest, Romania.
Neus Latorre-MargalefDepartment Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Héloïse LucaccioniEpiconcept, Paris, France.
Nuno VerdascaInfectious Disease Department, National Institute of Health, Lisbon, Portugal.
Antonino BellaDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Maria Angeles Rafael de la Cruz LopezEpidemiology Service, Directorate General of Public Health, Castilla-La Mancha, Spain.
Eva KellyHealth Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Vincent EnoufCentre National de Référence Virus des Infections Respiratoire, Institut Pasteur Université Paris Cité, Paris, France.
Kristin TolksdorfDepartment for Infectious Disease Epidemiology, Respiratory Infections Unit, Robert Koch Institute, Berlin, Germany.
Simona PuzelliDepartment of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Ana Carmen Ibáñez PérezDirectorate General of Public Health, Consumer Affaris and Care, La Rioja, Spain.
Margaret FitzgeraldHealth Service Executive-Health Protection Surveillance Centre, Dublin, Ireland.
Shirley MasseUnite des Virus Emergents, UVE: Aix-Marseille Univ, Universita di Corsica, IRD 190, Inserm 1207, IRBA, Marseille, France.
Djin-Ye OhDepartment for Infectious Diseases, Influenza and Other Respiratory Viruses Unit, National Reference Centre for Influenza Viruses, Robert Koch Institute, Berlin, Germany.
Marlena KaczmarekEuropean Centre for Disease Control and Prevention, Stockholm, Sweden.
Sabrina BacciEuropean Centre for Disease Control and Prevention, Stockholm, Sweden.
Esther KisslingEpiconcept, Paris, France.
VEBIS Primary Care Vaccine Effectiveness Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42295762
PMCPMC13270266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.